NO884756L - Fremgangsmaate for fremstilling av et nytt rekombinant lymfotoxin-derivat. - Google Patents

Fremgangsmaate for fremstilling av et nytt rekombinant lymfotoxin-derivat.

Info

Publication number
NO884756L
NO884756L NO88884756A NO884756A NO884756L NO 884756 L NO884756 L NO 884756L NO 88884756 A NO88884756 A NO 88884756A NO 884756 A NO884756 A NO 884756A NO 884756 L NO884756 L NO 884756L
Authority
NO
Norway
Prior art keywords
ser
arg
lys
gly
ala
Prior art date
Application number
NO88884756A
Other languages
English (en)
Norwegian (no)
Other versions
NO884756D0 (no
Inventor
Toshiaki Wakabayashi
Makoto Asada
Takeshi Nagasu
Yoshikazu Hasegawa
Yasushi Shikata
Manabu Kuwada
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO884756D0 publication Critical patent/NO884756D0/no
Publication of NO884756L publication Critical patent/NO884756L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO88884756A 1987-10-28 1988-10-26 Fremgangsmaate for fremstilling av et nytt rekombinant lymfotoxin-derivat. NO884756L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27203487 1987-10-28

Publications (2)

Publication Number Publication Date
NO884756D0 NO884756D0 (no) 1988-10-26
NO884756L true NO884756L (no) 1989-05-02

Family

ID=17508203

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88884756A NO884756L (no) 1987-10-28 1988-10-26 Fremgangsmaate for fremstilling av et nytt rekombinant lymfotoxin-derivat.

Country Status (6)

Country Link
EP (1) EP0314094A3 (da)
KR (1) KR890006820A (da)
AU (1) AU2431788A (da)
DK (1) DK596888A (da)
FI (1) FI884798A7 (da)
NO (1) NO884756L (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212207A (en) * 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
DE3686148T2 (de) * 1985-12-24 1993-01-14 Denki Kagaku Kogyo Kk Lymphotoxin-gen, verfahren zu dessen herstellung und lymphotoxin.
JPS62181298A (ja) * 1986-02-05 1987-08-08 Kyowa Hakko Kogyo Co Ltd ヒトリンホトキシンポリペプチド誘導体
DE3620656A1 (de) * 1986-06-20 1987-12-23 Basf Ag Polypeptide mit lymphotoxin-aktivitaet oder lymphotoxin-aehnlicher aktivitaet, ihre herstellung und verwendung
EP0272894A3 (en) * 1986-12-24 1989-06-14 Takeda Chemical Industries, Ltd. Recombinant human lymphotoxin

Also Published As

Publication number Publication date
EP0314094A3 (en) 1990-04-25
DK596888D0 (da) 1988-10-27
NO884756D0 (no) 1988-10-26
DK596888A (da) 1989-04-29
FI884798A0 (fi) 1988-10-18
EP0314094A2 (en) 1989-05-03
FI884798A7 (fi) 1989-04-29
KR890006820A (ko) 1989-06-16
AU2431788A (en) 1989-05-04

Similar Documents

Publication Publication Date Title
JP2561255B2 (ja) 組換コロニ−刺激因子▲下−▼１
US5288852A (en) Human tumor necrosis factor polypeptides
US7179790B2 (en) Brain natriuretic peptide
CA1341240C (en) Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide
JP2882775B2 (ja) ヒトーグリア由来神経突起因子
JP2864996B2 (ja) 免疫学的疾患治療用医薬組成物
JP2620479B2 (ja) 豚成長ホルモンのポリペプチドおよびその製造方法
WO2021120350A1 (zh) 白介素-2衍生物
NO301775B1 (no) DNA-sekvens som koder for nye former av kolonistimulerende faktor-1, vektor, ekspresjonssystem og rekombinant vertscelle
JPH05500806A (ja) Ｇｍ―ｃｓｆ及びｉｌ―３を含む融合タンパク質
CN88103118A (zh) 人前脱脂蛋白a-i的表达
JPH04281790A (ja) Ｄｎａおよびその用途
JP4493854B2 (ja) リガンドの生物学的活性を増強する方法
JPH04503812A (ja) メラニン濃縮ホルモンおよびそれを用いた処置法
JPH0866194A (ja) ヒト腫瘍壊死因子ミューテインをコードする遺伝子
NO174717B (no) Fremgangsmaate for fremstilling av et fiskeveksthormon-polypeptid fra Oncorhynchus keta samt ekspresjonsvektorer til bruk ved fremgangsmaaten
CA1339464C (en) ¬leu13| motilin, dnas coding for same and methods for producing same
Tamas et al. A β-turn rich barley seed protein is correctly folded in Escherichia coli
CN106008717B (zh) 一种长效重组glp-1融合蛋白及其制备方法和用途
NO884756L (no) Fremgangsmaate for fremstilling av et nytt rekombinant lymfotoxin-derivat.
EP0230781B1 (en) Lymphotoxin gene, method for its production, and lymphotoxin
JPH03297388A (ja) 新規なｔｎｆ変異体、その製造法及びそれを有効成分とする抗腫瘍剤
JPH06306100A (ja) Ｖｉｐアナログ調製用融合蛋白、ｖｉｐアナログの製法並びにそのための遺伝子組換えプラスミド及び形質転換微生物
JP2675294B2 (ja) ヒト腫瘍壊死因子
US5420113A (en) [Leu13]motilin, DNAs coding for same and methods for producing same